
Novo Nordisk
Novo Nordisk in Fortune Rankings
- About
- Great Place to Work
Novo Nordisk is a global healthcare company headquartered in Denmark, that develops and manufactures pharmaceutical products, focusing mainly on diabetes and obesity care. The company was founded in 1923 and provides product access in 170 markets worldwide.

Courtesy of UCG via Getty
- Company Information
- Perks
- Paid Time Off
- Compensation
- Hiring/staffing (past 12 Months)
- Millennials In The Organization
- Women In The Organization
- World's Most Admired Companies
- Best Companies To Work For Europe
- Europe's Most Innovative Companies
- Key Financials (last Fiscal Year)
- Profit Ratios
- Updated:16/09/2026
- Country/Territory:Denmark
- Headquarters:Bagsvaerd
- Industry:Pharmaceuticals
- CEO:Maziar Mike Doustdar
- Website:https://www.novonordisk.com
- Ticker:NVO
- Company type:Public
- Revenues ($M):$46,711
- Profits ($M):$15,482
- Market value ($M):$200,974
- Number of employees:69,505
Figures prepared in accordance with International Accounting Standards. Market Value as of Aug. 31, 2026. Sources: Regulatory filings; S&P Global.
- 100% health coverage:No
- Unlimited sick days:No
- Telecommuting:Yes
- Job sharing:Yes
- Subsidized childcare:Yes
- Compressed work weeks:Yes
- Fully-paid sabbaticals:No
- On-site fitness/subsidized gym:No
- On-site medical care facility:No
- Non-discrimination policy includes sexual orientation:Yes
- Health insurance for part-timers:Yes
- Sick days for part-timers:Yes
- College tuition reimbursement:Yes
- Student loan debt repayment:No
- Medical facility at all locations:No
- PTO limit (days):29
- # Sick days:10
- Most common job (for salaried employee):Sr. Diabetes Care Specialist
- Avg. base pay (salaried):$107,300
- Avg. extra compensation (salaried):$32,300
- Total pay for most common job (salaried):$139,600
- # of job applicants:19,219
- Avg. # of applicants per opening:18
- # New graduates hired:8
- # of millennial employees:802
- Millennials as % of total workforce:18%
- % of Women in the Company:57%
- % of Women in Executive/Manager Positions:43%
- Sector:Natural resources
- Industry:Pharmaceuticals
- Current All-Star Rank:46
- Previous All-Star Rank:-
- Industry Rank:2
- Previous Industry Rank:4
- Overall Score:7.63
- Innovation:2
- People Management:4
- Use of Corporate Assets:3
- Social Responsibility:1
- Quality of Management:2
- Financial Soundness:3
- Long-Term Investment Value:2
- Quality of Products/Services:2
- Global Competitiveness:3
- Sector:Health Care
- CEO/Top executive:Maziar Doustdar
- Group headquarters:Denmark
- HQ location:Denmark
- GPTW national list:Austria, France, Ireland, Poland, Portugal, Turkey
- Woman CEO:no
- Number of Years on List:2
- Sector:Health Care
- Country:Denmark
- Strongest dimension:Process innovation
- Years on list:2
- Previous rank:7
- $ Millions% change
- Revenues ($M):$46,71110.92%
- Profits ($M):$15,4825.72%
- Assets ($M):$85,369-
- Total Stockholder Equity ($M):$30,513-
- Profit as % of Revenues:33.1%
- Profits as % of Assets:18.1%
- Profits as % of Stockholder Equity:50.7%
Novo Nordisk stock chart
Latest news on Novo Nordisk
Novo Nordisk in Fortune Rankings
- Fortune 500 Europe
- Fortune Global 500
- Europe's Most Innovative Companies
- Fortune 100 Best Companies To Work For – Europe
- World's Most Admired Companies
- Best Large Workplaces in New York
- Best Large Workplaces in Biotechnology and Pharmaceuticals
- World’s 25 Best Workplaces
- Fortune 100 Best Companies to Work For
- 100 Best Large Workplaces for Millennials
- 100 Best Large Workplaces for Women
- Change the World
